Literature DB >> 24853772

Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain.

Lee Tran1, Jay Schulkin2, Beverley Greenwood-Van Meerveld3.   

Abstract

Corticotropin-releasing factor (CRF)-mediated mechanisms in the bed nucleus of the stria terminalis (BNST) have a pivotal role in stress-induced anxiety and hyperalgesia. Although CRF is known to activate two receptor subtypes, CRF1 and CRF2, attempts to delineate the specific role of each subtype in modulating anxiety and nociception have been inconsistent. Here we test the hypothesis that CRF1 and CRF2 receptor activation in the anteriolateral BNST (BNSTAL) facilitates divergent mechanisms modulating comorbid anxiety and hyperalgesia. Microinfusions of the specific antagonists CP376395 and Astressin2B into the BNSTAL were used to investigate CRF1 and CRF2 receptor functions, respectively. We found that CRF1 and CRF2 receptors in the BNSTAL had opposing effects on exploratory behavior in the elevated plus-maze, somatic mechanical threshold, and the autonomic and endocrine response to stress. However, CRF1 or CRF2 receptor antagonism in the BNSTAL revealed complementary roles in facilitating the acoustic startle and visceromotor reflexes. Our results suggest that the net effect of CRF1 and CRF2 receptor activation in the BNSTAL is pathway-dependent and provides important insight into the CRF receptor-associated circuitry that likely underpins stress-induced pathologies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24853772      PMCID: PMC4207343          DOI: 10.1038/npp.2014.117

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  68 in total

1.  Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis.

Authors:  Hong-Wei Dong; Larry W Swanson
Journal:  J Comp Neurol       Date:  2004-01-06       Impact factor: 3.215

2.  Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats.

Authors:  Satoshi Deyama; Takayuki Nakagawa; Shuji Kaneko; Takashi Uehara; Masabumi Minami
Journal:  Behav Brain Res       Date:  2006-11-13       Impact factor: 3.332

3.  Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients.

Authors:  Bruce D Naliboff; Steve Berman; Brandall Suyenobu; Jennifer S Labus; Lin Chang; Jean Stains; Mark A Mandelkern; Emeran A Mayer
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

4.  Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats.

Authors:  Chih-Yen Chen; Akio Inui; Akihiro Asakawa; Kazunori Fujino; Ikuo Kato; Chih-Chuan Chen; Naohiko Ueno; Mineko Fujimiya
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

5.  Maturation of the circadian rhythm of plasma corticosterone in the rat.

Authors:  C Allen; J W Kendall
Journal:  Endocrinology       Date:  1967-05       Impact factor: 4.736

6.  Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.

Authors:  Lacey L Sahuque; Erika F Kullberg; Andrew J Mcgeehan; Jennifer R Kinder; Megan P Hicks; Mary G Blanton; Patricia H Janak; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2006-03-28       Impact factor: 4.530

7.  Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia.

Authors:  Sylvie Bradesi; Ines Schwetz; Helena S Ennes; Christophe M R Lamy; Gordon Ohning; Michael Fanselow; Charalabos Pothoulakis; James A McRoberts; Emeran A Mayer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-03-03       Impact factor: 4.052

8.  Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders.

Authors:  Donald G Rainnie; Richard Bergeron; Tammy J Sajdyk; Madhvi Patil; Donald R Gehlert; Anantha Shekhar
Journal:  J Neurosci       Date:  2004-04-07       Impact factor: 6.167

9.  Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.

Authors:  Victoria B Risbrough; Richard L Hauger; Amanda L Roberts; Wylie W Vale; Mark A Geyer
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

10.  Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

Authors:  Timothy G Dinan; Eamonn M M Quigley; Salah M M Ahmed; Paul Scully; Sinead O'Brien; Liam O'Mahony; Siobhan O'Mahony; Fergus Shanahan; P W Napoleon Keeling
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

View more
  31 in total

1.  κ-Opioid Receptor Modulation of GABAergic Inputs onto Ventrolateral Periaqueductal Gray Dopamine Neurons.

Authors:  Chia Li; Thomas L Kash
Journal:  Mol Neuropsychiatry       Date:  2019-05-17

2.  Repeated norepinephrine receptor stimulation in the BNST induces sensorimotor gating deficits via corticotropin releasing factor.

Authors:  Abha Karki Rajbhandari; Vaishali P Bakshi
Journal:  Neuropharmacology       Date:  2020-04-29       Impact factor: 5.250

Review 3.  Stress-induced pain: a target for the development of novel therapeutics.

Authors:  Anthony C Johnson; Beverley Greenwood-Van Meerveld
Journal:  J Pharmacol Exp Ther       Date:  2014-09-05       Impact factor: 4.030

4.  Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response.

Authors:  Alexa Orand; Bruce Naliboff; Malin Gadd; Wendy Shih; Tiffany Ju; Angela P Presson; Emeran A Mayer; Lin Chang
Journal:  Psychoneuroendocrinology       Date:  2016-07-19       Impact factor: 4.905

5.  Corrigendum to "Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways" [Exp Neurol. 2015 Nov.; 273: 301-11].

Authors:  Gen Zheng; Shuangsong Hong; John M Hayes; John W Wiley
Journal:  Exp Neurol       Date:  2016-03-08       Impact factor: 5.330

Review 6.  Region-specific roles of the corticotropin-releasing factor-urocortin system in stress.

Authors:  Marloes J A G Henckens; Jan M Deussing; Alon Chen
Journal:  Nat Rev Neurosci       Date:  2016-09-02       Impact factor: 34.870

Review 7.  The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?

Authors:  Matthew B Pomrenze; Tracy L Fetterly; Danny G Winder; Robert O Messing
Journal:  Alcohol Clin Exp Res       Date:  2017-10-25       Impact factor: 3.455

Review 8.  The peripheral corticotropin-releasing factor (CRF)-induced analgesic effect on somatic pain sensitivity in conscious rats: involving CRF, opioid and glucocorticoid receptors.

Authors:  Natalia I Yarushkina; Ludmila P Filaretova
Journal:  Inflammopharmacology       Date:  2018-02-05       Impact factor: 4.473

9.  Characterization and gonadal hormone regulation of a sexually dimorphic corticotropin-releasing factor receptor 1 cell group.

Authors:  Zachary J Rosinger; Jason S Jacobskind; Nicole Bulanchuk; Margaret Malone; Danielle Fico; Nicholas J Justice; Damian G Zuloaga
Journal:  J Comp Neurol       Date:  2018-12-24       Impact factor: 3.215

Review 10.  Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.

Authors:  Yvette Tache; Muriel Larauche; Pu-Qing Yuan; Mulugeta Million
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.